Concepedia

Dimitrios Tzachanis

DT

Statistics

Publications

37

Citations

3.1K

H-Index

24

Active since

2001

Affiliations

University of California San Diego(Current)

Dana-Farber Cancer Institute

Moffitt Cancer Center

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Dimitrios Tzachanis is an author at University of California San Diego specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2001–2025

37

Publications

37

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 769 citations · Full text

, , +9

PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine

Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills et al. · Journal of Immunotherapy · 2011 · 282 citations

, , +17

Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells

Dimitrios Tzachanis, Gordon J. Freeman, Naoto Hirano et al. · Nature Immunology · 2001 · 275 citations

, , +12

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

Mark R. Litzow, Zhuoxin Sun, Ryan J. Mattison et al. · New England Journal of Medicine · 2024 · 215 citations · Full text

, , +16

Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

Olalekan O. Oluwole, Krimo Bouabdallah, Javier Muñoz et al. · British Journal of Haematology · 2021 · 214 citations · Full text

, , +17

1–5 of 37